A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia

Clinical Microbiology and Infection

Volumn 21, Issue 12, 2015, Pages 1093.e1-1093.e7

  Alanin, M C ^a   Nielsen, K G ^a   von Buchwald, C ^a   Skov, M ^a   Aanaes, K ^a   Hoiby N ^a,b   Johansen, H K ^a,c  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Chalmers University of Technology   (Denmark)

Author keywords

Ciliary motility disorders; Kartagener's syndrome; Mucociliary clearance; Pseudomonas aeruginosa; Pulse field gel electrophoresis

Indexed keywords

CIPROFLOXACIN; COLISTIN;

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CILIARY DYSKINESIA; CLINICAL ARTICLE; CROSS INFECTION; DISEASE TRANSMISSION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MALE; MORAXELLA CATARRHALIS; MYCOBACTERIUM ABSCESSUS; NEWBORN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; AGE; BACTERIUM; CLASSIFICATION; ISOLATION AND PURIFICATION; KARTAGENER SYNDROME; LONGITUDINAL STUDY; LUNG; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BACTERIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KARTAGENER SYNDROME; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84951031296     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.08.020     Document Type: Article

References (28)

1. Werner C., Onnebrink J.G., Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia 2015, 4:2.
2. Noone P.G., Leigh M.W., Sannuti A., Minnix S.L., Carson J.L., Hazucha M., et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004, 169:459-467.
3. Maglione M., Bush A., Nielsen K.G., Hogg C., Montella S., Marthin J.K., et al. Multicenter analysis of body mass index, lung function, and sputum microbiology in primary ciliary dyskinesia. Pediatr Pulmonol 2014, 49:1243-1250.
4. Rogers G.B., Carroll M.P., Zain N.M., Bruce K.D., Lock K., Walker W., et al. Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia. J Clin Microbiol 2013, 51:4029-4035.
5. Davis S.D., Ferkol T.W., Rosenfeld M., Lee H.S., Dell S.D., Sagel S.D., et al. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. Am J Respir Crit Care Med 2015, 191:316-324.
6. Barbato A., Frischer T., Kuehni C.E., Snijders D., Azevedo I., Baktai G., et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009, 34:1264-1276.
7. Johansen H.K., Moskowitz S.M., Ciofu O., Pressler T., Høiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008, 7:391-397.
8. Ojeniyi B., Frederiksen B., Høiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000, 29:177-181.
9. Johansen H.K., Norregaard L., Gotzsche P.C., Pressler T., Koch C., Høiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? - a 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 2004, 37:427-432.
10. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
11. Proesmans M., Balinska-Miskiewicz W., Dupont L., Bossuyt, Verhaegen J., Høiby N., et al. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006, 27:937-943.
12. Standardization of Spirometry 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995, 152:1107-1136.
13. Høiby N., Koch C. Maintenance treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Thorax 2000, 55:349-350.
14. Høiby N., Jacobsen L., Jorgensen B.A., Lykkegaard E., Weeke B. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against Pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs. Acta Paediatr Scand 1974, 63:843-848.
15. Høiby N., Flensborg E.W., Beck B., Friis B., Jacobsen S.V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Resp Dis 1977, 58:65-79.
16. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
17. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:918-951.
18. Goddard A.F., Staudinger B.J., Dowd S.E., Joshi-Datar A., Wolcott R.D., Aitken M.L., et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012, 109:13769-13774.
19. Pasteur M.C., Bilton D., Hill A.T. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010, 65(Suppl. 1):i1-58.
20. Kapur N., Grimwood K., Masters I.B., Morris P.S., Chang A.B. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2012, 47:300-307.
21. Marvig R.L., Sommer L.M., Molin S., Johansen H.K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 2015, 47:57-64.
22. Alanin M.C., Johansen H.K., Aanaes K., Høiby N., Pressler T., Skov M., et al. Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia. Acta Otolaryngol 2015, 135:58-63.
23. Johansen H.K., Aanaes K., Pressler T., Nielsen K.G., Fisker J., Skov M., et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 2012, 11:525-531.
24. Jelsbak L., Johansen H.K., Frost A.L., Thøgersen R., Thomsen L.E., Ciofu O., et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007, 75:2214-2224.
25. Bonestroo H.J., de Winter-de Groot K.M., van der Ent C.K., Arets H.G. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J Cyst Fibros 2010, 9:130-134.
26. Marthin J.K., Petersen N., Skovgaard L.T., Nielsen K.G. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 2010, 181:1262-1268.
27. Hosie P.H., Fitzgerald D.A., Jaffe A., Birman C.S., Rutland J., Morgan L.C. Presentation of primary ciliary dyskinesia in children: 30 years' experience. J Paediatr Child Health 2015, 51:722-726.
28. Green D.M., Collaco J.M., McDougal K.E., Naughton K.M., Blackman S.M., Cutting G.R. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr 2012, 161:290-295.